Search
for
Sort by
Research 151–180 of 1000+
- Clinical use of 5α-reductase inhibitors
- A Chance Finding of High Grade Prostate Cancer in a 35-Year-Old Male – A Case Report and Outcomes of Robotic Radical Prostatectomy in Young Men with Prostate Cancer
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
- The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy
- STUDIED ON TOXICITY OF HYDROCORTISONE 17-BUTYRATE 21-PROPIONATE : 6. Subacute Toxicity in Dogs by Percutaneous Adminisration
- Pharmacology of antiandrogens
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Should Finasteride Be Routinely Given Preoperatively for TURP?
- Is dehydroepiandrosterone a hormone?
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- 9 Role of 5α-reductase in health and disease
- The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men
- Anti-androgenic activities of Ganoderma lucidum
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Androgen antagonists in androgen target tissues
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia
- Cardiovascular effects of hormone therapy for prostate cancer
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Therapeutic Androgen Receptor Ligands
- Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case–control series of veterans
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Male pattern baldness and incidence of prostate cancer
- Physiology and Medical Treatments for Alopecia